Status:

UNKNOWN

Muscle Function, Central Nervous System Sensitization, and Pain Profiling in Patients With Subacromial Pain (SAP-CNSS).

Lead Sponsor:

Hvidovre University Hospital

Collaborating Sponsors:

Physical Medicine and Rehabilitation Research - Copenhagen (PMR-C).

School of Physiotherapy, Metropolitan University College Copenhagen.

Conditions:

Subacromial Impingement Syndrome

Central Nervous System Sensitization

Eligibility:

All Genders

18-65 years

Brief Summary

In this case-control study, the investigators compare shoulder muscle function, pain, and central nervous system sensitization in patients with Subacromial Pain (SAP) to that in healthy controls. The ...

Detailed Description

Subacromial pain (SAP), also referred to as subacromial impingement syndrome, is characterized by pain in the shoulder joint, which is aggravated by elevation of the arm and / or during overhead activ...

Eligibility Criteria

Inclusion

  • Have had SAP during the last two weeks or more.
  • Have positive results from minimum 3 out of 5 clinical tests.
  • Have experienced pain ranking 4 or above on the VRS scale within the last 7 days.
  • Are able to speak and understand Danish.
  • Have given informed consent to participate in the study after they have fully understood the content of the study.

Exclusion

  • Have acquired traumatic shoulder injury, and this is onset/cause for current shoulder pain, e.g. fall on shoulder.
  • Have received a corticosteroid injection within the last six weeks.
  • Report having had a shoulder fracture within 6 months.
  • Report having had surgery on the affected shoulder.
  • Report having radiologically verified glenohumeral osteoarthritis.
  • Have a luxation or sub-luxation of the glenohumeral or the acromioclavicular joint, clinically suspected labrum lesion, clinically suspected complete traumatic tear of the rotator cuff, frozen shoulder, suspected competing diagnoses (i.e. rheumatoid arthritis, cancer, neurological disorders, and fibromyalgia).
  • Have a history of diagnosed major psychiatric disorder.
  • Have a history of illicit drug use; be currently abusing alcohol or currently withdrawing from alcohol abuse.
  • Have a history of heart disease.
  • Are pregnant.

Key Trial Info

Start Date :

November 13 2017

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

July 31 2020

Estimated Enrollment :

72 Patients enrolled

Trial Details

Trial ID

NCT03326466

Start Date

November 13 2017

End Date

July 31 2020

Last Update

February 21 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hvidovre University Hospital

Hvidovre, Sealand, Denmark, 2650